CpG-mediated Augmentation of CD8+ T-Cell Responses in Mice are Attenuated by a Water-in-Oil Emulsion (Montanide ISA-51) but Enhanced by an Oil-in-Water Emulsion (IDRI SE).

Adjuvants are a key component in enhancing immunogenicity of vaccines and play a vital role in facilitating the induction of the correct type of immunity required for each vaccine to be optimally efficacious. Several different adjuvants are found in licensed vaccines, and many others are in pre-clinical or clinical testing. Agonists for Toll-like receptors (TLR) are potent activators of the innate immune system and some, such as CpG (TLR9 agonist) are particularly good for promoting cellular immunity due to the induction of Th1 cytokines. Emulsions, which have both delivery and adjuvant properties, are classified as water-in-oil (W/O) or oil-in-water (O/W) formulations. The W/O emulsion Montanide ISA-51, often combined with CpG, has been widely tested in cancer vaccine clinical trials. Squalene-based O/W emulsions are in licensed influenza vaccines and T cell responses have been assessed pre-clinically. No clinical study has compared the two types of emulsions and the continued use of W/O with CpG in cancer vaccines may be because the lack of single adjuvant controls has masked the interference issue. These findings may have important implications for development of vaccines where T cell immunity is considered essential, such as those for cancer and chronic infections. Using particulate (HBsAg) and soluble protein (ovalbumin) antigen, we show in mice that a W/O emulsion (ISA-51) abrogates CpG-mediated augmentation of CD8+ T cell responses, whereas a squalene-based O/W emulsion significantly enhanced them.
© The Japanese Society for Immunology. 2016. All rights reserved. For permissions, please e-mail: [email protected].

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!